OKYO Pharma Limited
OKYO
Positions held
Your positionsOKYO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $72.95M | Enterprise value | $52.35M | Trailing P/E | — | Forward P/E | -2.11 |
| PEG | — | Price / book | 5.91 | Beta | -0.06 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -2.6% | ROA | -43.1% | Debt / equity | — |
| Current ratio | 2.43 | Free cash flow | -$2.10M | Analyst recommendation | strong_buy | Mean target | $8.33 |
| 52w high | $3.20 | 52w low | $1.27 |
Quarterly
No data yet.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$8.9M | -$4.7M | -$16.8M | -$13.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$8.5M | -$7.1M | -$15.7M | -$13.2M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · OKYO Pharma enrolls first patients in Phase 3 trial of neuropathic corneal pain drug
2026-10-06 · OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
2026-09-29 · OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
2026-09-09 · OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
2026-09-08 · OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
2026-07-28 · OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
2026-07-28 · OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
2026-07-27 · OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
2026-07-23 · OKYO Pharma Announces Purchase of Shares by Director
2026-07-23 · OKYO Pharma Announces Purchase of Shares by Director
2026-07-23 · OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
2026-07-23 · OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
Price (daily)
Full chart · RSI · MACD · patterns